News
- Kindred Biosciences Initiates Pivotal Efficacy Study of Tirnovetmab (Interleukin-31) Monoclonal Antibody for Canine Atopic DermatitisDecember 22, 2020 8:31 AM EST
- Kindred Biosciences Announces Positive Results from Pilot Field Effectiveness Study for Anti-TNFα Antibody for Canine Inflammatory Bowel DiseaseDecember 21, 2020 8:31 AM EST
- Kindred Biosciences Announces Agreement Granting Elanco Exclusive Global Rights for its Parvovirus Monoclonal AntibodyDecember 11, 2020 8:00 AM EST
Events
- Monday, December 7, 2020 10:00 AM EST
- Thursday, November 19, 2020
- Tuesday, November 17, 2020 from 2:40 PM to 3:10 PM EST
|
KindredBio proudly supports
Rabies Free Africa
Press Release
Interested parties may access the call by dialing toll-free (855) 433-0927 from the US, or (484) 756-4262 internationally, and using conference ID 8962269.
The call will also be webcast live at https://edge.media-server.com/m6/p/w3hyojgg.
A replay will also be available at that link for 30 days.
AboutKindred Biosciences
For more information or to download the corporate presentation, visit www.KindredBio.com/LearnMore. Stay connected with KindredBio onFacebook at www.Facebook.com/KindredBio.
Contact
KindredBio
russell.radefeld@kindredbio.com
(650) 701-7904
SOURCEKindred Biosciences, Inc.